Planmeca completed the acquisition of the KaVo Treatment Unit and Instrument business of Envista for $455m.

Planmeca, a Finnish manufacturer of high-tech dental equipment, completed the acquisition of the KaVo Treatment Unit and Instrument business of Envista, a global family of more than 30 trusted dental brands, for $455m. "Envista is focused on its strategic priorities to build and optimize a more consumables and digitally enabled, workflow-oriented portfolio. This sale will better position Envista to invest organically and inorganically and expand our product offerings within these areas," Amir Aghdaei, Envista CEO.